Johnson & Johnson (NYSE: JNJ)
You’re reading a free stock page from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
Johnson & Johnson Return vs. S&P
1 Year | 5 Year | 5 Year Annualized | Since IPO |
---|
Johnson & Johnson Company Info
Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer Health, Pharmaceutical, and MedTech. The Consumer Health segment includes products focused on personal healthcare used in the Skin Health/Beauty, Over-the-Counter medicines, Baby Care, Oral Care, Women’s Health and Wound Care markets. The Pharmaceutical segment focuses on therapeutic areas, such as immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. The MedTech segment offers products used in the interventional solutions. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.
News & Analysis
Got $2,500? 2 Top Stocks That You Can Buy and Hold for a Lifetime
These elite companies make exceptional foundational investments for any portfolio.
The Best S&P 500 Index Funds
Find out which index funds tracking the S&P 500 have the lowest fees and most closely track the market.
Dividend Kings of 2023
Get a list of current -- and potential future -- Dividend Kings and learn how to leverage these strong companies to build wealth.
3 Pharma Stocks That Are Screaming Buys in October
Each company delivers an above-average dividend and revenue growth.
What Are Widow and Orphan stocks?
2 Exceptional Dividend Stocks Near 52-Week Lows. Are They Bargains Now?
Attractive valuation metrics don't always tell the whole story.
3 High-Yielding Dividend Stocks Near Their 52-Week Lows
Due to their declining share prices, Johnson & Johnson, Bank of America, and Target all yield more than 3% right now.
2 Historically Cheap Dow Dividend Kings That Are Ripe for the Picking
These inexpensive Dow components have achieved royalty status among income stocks -- more than 60 consecutive years of dividend increases.
Valuation
Podcast Episodes
An Investor's View of Johnson & Johnson's Talc Settlement
We also take a look at Chewy's growth initiatives.
Johnson & Johnson's Big Purchase, Amazon's New Moves, and More
Plus, we run through some shortcuts that could help you with your financial planning.
Times Like These Are Why You Want to Own a Business Like This
Plus, a look at the 4% rule and a common misconception about retirement spending.
Making Sense of Financial Advice on TikTok
Plus a look at what to like about Johnson & Johnson.
Earnings Transcripts
Johnson & Johnson (JNJ) Q3 2023 Earnings Call Transcript
JNJ earnings call for the period ending September 30, 2023.
Johnson & Johnson (JNJ) Q2 2023 Earnings Call Transcript
JNJ earnings call for the period ending June 30, 2023.
Johnson & Johnson (JNJ) Q4 2022 Earnings Call Transcript
JNJ earnings call for the period ending December 31, 2022.
Johnson & Johnson (JNJ) Q3 2022 Earnings Call Transcript
JNJ earnings call for the period ending September 30, 2022.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.